Since IL-19 and IGF1 were associated with Th17 cells and our results also showed that the expression of both IL-19 and IGFL1 was upregulated in chronic lesions, we speculated that IL-19 and IGFL1 might be new indicators of AD chronicity. This evidence concerns the gene IL19 and Alzheimer disease.